Skip to main content
SpringerLink
Log in

Antidepressiva: Grundlagen und Therapie

  • Chapter
Psychopharmaka

Zusammenfassung

Die theoretische und klinische Entwicklung der Antidepressiva nahm ihren Ausgang von den Entdeckungen der antidepressiven Wirkung von Imipramin durch Kuhn [187] und von Iproniazid durch Kline [176]. Der „ersten Generation “ von zahlreichen trizyklischen Antidepressiva bzw. Monoaminoxidase (MAO)-Hemmern folgte die Entwicklung der „zweiten Generation“, d. h. antidepressiv wirksame Substanzen, die strukturchemisch und teilweise auch pharmakologisch keine Verwandtschaft mit den „klassischen“ Antidepressiva aufweisen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agnoli, A. (1974): Trazodone versus desipramine: a double-blind study on the rapidity of the antidepressive effect. In: Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973. Modern Problems of Pharmacopsychiatry, Vol. 9 Ban, T. A., Silvestrini, B. (Hrsg.). Basel: Karger.

    Google Scholar 

  2. Agnoli, A. (1975): Psychopharmacological effects of trazodone, results of clinical studies. J. Pharm. Clin. 2, 219–225.

    Google Scholar 

  3. Alexanderson, B. (1972): Pharmacokinetics of nortriptyline in man after single and multiple oral doses. The predictability of steady state plasma concentrations from single-dose plasma level data. Eur. J. clin. Pharmacol. 4, 82–83.

    PubMed  CAS  Google Scholar 

  4. Alexanderson, B., Evans, D. A. P., Sjöqvist, F. (1969): Steady-state plasma le vels of nortriptyline in twins: influence of genetic factors and drug therapy. Br. Med. J. 4, 764–768.

    PubMed  CAS  Google Scholar 

  5. Alkalay, D., Wagner, W. E., Jr., Carlsen, S. Khemani, L., Volk, J., Barlett, F. an Le Sher, A. (1980): Bioavailibility and kinetics of maprotiline. Clin. Pharmacol. Therap. 27, 697–703.

    CAS  Google Scholar 

  6. Angst, J. (1961): A clinical analysis of the effects of Tofranil in depression: longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacol. (Berl.) 2, 381–407.

    CAS  Google Scholar 

  7. Angst, J. (1963): Insidon als Antidepressivum: Vergleich mit Trofanil: Katamnesen. Nervenarzt 34, 76–80.

    PubMed  CAS  Google Scholar 

  8. Angst, J. (1978): Drug-evaluation. In: Neuro-Psychopharmacology (Proceedings of the 10th Congress of the C. I. N. P.) ( Deniker, P., Raduoco-Thomas, C., Vllle-Neuve, A., Hrsg.), S. 1023–1031. Oxford- New York: Pergamon Press.

    Google Scholar 

  9. Angst, J., Theobald, W., Bleuler, M., Kuhn, R. (1970): Tofranil (imipramine). Bern: Stampfli and Cie.

    Google Scholar 

  10. Angst, J. (1977): The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch. Psychiat. Ner-venkr. 224, 175–186.

    CAS  Google Scholar 

  11. Antonaccio, M. J., Robson, R. D. (1975): The cardiovascular pharmacology of antidepressants. In: Antidepressants ( Fielding, S., Lal, H., Hrsg.), S. 181–207. Futura Publ. Co.

    Google Scholar 

  12. Aprison, M. H., Takahashi, R., Tachiki, K. (1978): Hypersensitive serotonergic receptors involved in clinical depression — a theory. In: Neuropharmacology and behavior ( Haber, B., Aprison, M. H., Hrsg., S. 23–53. New York–London: Plenum Press.

    Google Scholar 

  13. Arnould, P. (1979): Nomifensine (Alival) in the treatment of depression in the elderly. Med. Actuelle 6, 111.

    Google Scholar 

  14. Asberg, M., Cronholm, B., Sjöqvist, F., Tuck, D. (1971): Relationship between plasma level and therapeutic effect of nortriptyline. Br. med. J. 3, 331–337.

    PubMed  CAS  Google Scholar 

  15. Asberg, M., Thoren, P., Träskman, L., Bertilsson, L., Ringberger, V.-A. (1976): „Serotonin depression“ — A biochemical subgroup within the affective disorders? Science 191, 478–480.

    Google Scholar 

  16. Aylward, M.: Presented at a meeting of the Royal College of Physicians, January 1976.

    Google Scholar 

  17. Baldessarini, R. J. (1980): Drugs and the treatment of psychiatric disorders. In: The Pharmacological Basis of Therapeutics ( Goodman-Gilman, A., Goodman, L. S., Gilman, A., Hrsg.), S. 391–447. New York–Toronto–London: Macmillan.

    Google Scholar 

  18. Ban, T. (1981): Psychopharmacology of Depression. A Guide for Drug Treatment. Basel - München - Paris - London - New- York - Sidney: Karger.

    Google Scholar 

  19. Ban, T. A., McEvoy, J. P., Wilson, W. H. (1980): Viloxazine: a review of the literature. Int. Pharmacopsychiat. 15, 118–123.

    CAS  Google Scholar 

  20. Baumann, P. A., Maitre, L. (1975): Blok-kade of presynaptic a-receptor in rat cortex by antidepressants. Experientia 31, 726.

    Google Scholar 

  21. Baumann, P. A., Maitre, L. (1977): Blok-kade of presynaptic a-receptors and of amine uptake in the rat brain by the antidepressant mianserin. Naunyn-Schmiede-berg’s Arch. Pharmacol. 300, 31–37.

    CAS  Google Scholar 

  22. Beckmann, H. (1978): Biochemische Grundlagen der endogenen Depression. Nervenarzt 49, 557–568.

    PubMed  CAS  Google Scholar 

  23. Beckmann, H. (1981): Die medikamentöse Therapie der Depressionen. Nervenarzt 52, 135–146.

    PubMed  CAS  Google Scholar 

  24. Beckmann, H. (1979): DL-phenylalanine versus imipramine: a double-blind controlled study. Arch. Psychiat. Nervenkr. 227, 49–58.

    PubMed  CAS  Google Scholar 

  25. Beckmann, H. (1977): DL-phenylalanine in depressed patients: an open study. J. Neural Transm. 41, 123–134.

    PubMed  CAS  Google Scholar 

  26. Belmaker, R. H. Zohar, J. (1982): Salbutamol treatment of depression. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 181–193. New York: Raven Press.

    Google Scholar 

  27. Bene-Sovà, O. (1967): The relation of imi-pramine-like drugs to the cholinergic system. In: Antidepressants Drugs (Garattini, S., Dukes, M. N. G., Hrsg. ). Excerpta Medica.

    Google Scholar 

  28. Benkert, O., Hippius, H. (1980): Psychiatrische Pharmakotherapie. Berlin - Heidelberg - New York: Springer.

    Google Scholar 

  29. Biamino, G. (1977): Comparative studies on the cardiovascular activity of tricyclic antidepressants and nomifensine (Alival, Meritai) in vitro and in vivo. In: Ali-val-Symposium über Ergebnisse der experimentellen und klinischen Prüfung, S. 129. Stuttgart: Schattauer.

    Google Scholar 

  30. Bickel, M. H. (1980): Metabolism of antidepressants. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, part 1 ( Hoffmeister, F., Stille, G., Hrsg.), S. 551–572. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  31. Biel, J. H., Bopp, B. (1974): Antidepressant drugs. In: Medicinal Chemistry (De Stevens, G, Hrsg.), Vol. 4/III, S. 283–341. New York: Academic Press.

    Google Scholar 

  32. Bielski, R. J., Friedel, R. O. (1976): Prediction of tricyclic antidepressant response. Arch. Gen. Psychiat. 33, 1479–1489.

    PubMed  CAS  Google Scholar 

  33. Birkmayer, W. (1966): Experimentelle Befunde und neue Aspekte bei extrapyramidalen Erkrankungen. Wien. Z. Nerven-heilkd. 13, 128–139.

    Google Scholar 

  34. Böning, J. (1982): Zentralmotorische und extrapyramidale Nebenwirkungen unter Therapie mit Antidepressiva Fortschr. Neurol. Psychiat. 50, 35–47.

    Google Scholar 

  35. Bournerias, F., Habibi, B. (1979): Nomi-fensine-induced immune haemolytic anaemia and impaired renal function. Lancet ii, 95–96.

    Google Scholar 

  36. Bradley, P. B., Key, B. J. (1959): A comparative study of the effects of drugs on the arousal system of the brain. Br. J. Pharmacol. 14, 340–349.

    CAS  Google Scholar 

  37. Brimbelcombe, R. W. (1974): In: Drug actions on cholinergic systems (Bradley, P. B., Macmillan, Hrsg.).

    Google Scholar 

  38. Brodie, H. K. H., Sack, R., Siever, L. (1973): Clinical studies of L-5-hydrox-ytryptophan in depression. In: Serotonin and Behavior ( Barchas, J., Usdin, E., Hrsg.), S. 549–559. New York: Academic Press.

    Google Scholar 

  39. Brogden, R. N., Hell, R. C:, Speight, I. M., Avery, G. S. (1978): Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16, 273–301.

    Google Scholar 

  40. Brown, W. A., Johnston, R., Mayfield, D. (1979): The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am. J. Psychiat. 136, 543–547.

    PubMed  CAS  Google Scholar 

  41. Brückner, G. W., Jansen, W. (1977): The use of nomifensine in geriatric patients. In: Alival-Symposium über Ergebnisse der experimentellen und klinischen Prüfung, S. 273. Stuttgart: Schattauer.

    Google Scholar 

  42. Brunner, H., Hedwall, P. R., Meier, M., Bein, H. J. (1971): Cardiovascular effects of preparation CIBA 34, 276 Ba and imi-pramine. Agents and actions 2, 69–82.

    CAS  Google Scholar 

  43. Bunney, W. E., Brodie, H. K. H., Murphy, D. (1971): The „switch process“ in manic-depressive illness. III. Theoretical implications. Arch. Gen. Psychiat. 127, 872–881.

    CAS  Google Scholar 

  44. Bunney, W. E., Davis, J. W. (1965): Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiat. 13, 483–494.

    PubMed  CAS  Google Scholar 

  45. Burrows, G. D., Vohra, J. K, Dumovic, P., Scoggins, B. A., Davies, B. (1978): Cardiological effects of nomifensine a new antidepressant. Med. J. Aust. 1, 341.

    Google Scholar 

  46. Calanca, A., Jalonetzky, S. (1977): Etude clinique d’un nouvel antidépressif, la Miansérine. Méd. et Hyg. 35, 364–367.

    Google Scholar 

  47. Cancro, R. (1982): Experience with a new rapid-acting antidepressant: amoxapine. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 121–124. New York: Raven Press.

    Google Scholar 

  48. Carlsson, A., Corrodi, H., Fuxe, K, Hökfelt, T. (1969): Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-a-ethyl-metad-tyramine. Eur. J. Pharmacol. 5, 357–366.

    PubMed  CAS  Google Scholar 

  49. Carlton, P. L. (1961): Potentiation of the behavioral effects of amphetamine by imi-pramine. Psychopharmacol. 2, 364–376.

    CAS  Google Scholar 

  50. Carroll, B. J., Feinberg, M., Steiner, M., Haskett, R. F., James, N. M., Tarika, J. (1980): Diagnostic Application of the Dexamethasone Suppression Test in Depresses Outpatients. Adv. biol. Psychiat. Vol. 5, S. 107–116. Basel: Karger.

    Google Scholar 

  51. Carroll, B. J., Mowbray, R. M., Davies, B. (1970): Sequential comparison of L-tryptophan with ECT in severe depression. Lancet i, 967–969.

    PubMed  CAS  Google Scholar 

  52. Chen, C. N. (1979): Sleep, depression and antidepressants. Br. J. Psychiat. 135, 385–402.

    CAS  Google Scholar 

  53. Chiodo, L. A., Antelman, S. M. (1980): Electroconvulsive shock: progressive auto-receptor subsensitivity independent of repeated treatment. Science 210, 799–801.

    PubMed  CAS  Google Scholar 

  54. Chiodo, L. A., Antelman, S. M. (1980): Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily treatment. Nature 287, 451–454.

    PubMed  CAS  Google Scholar 

  55. Chouinard, G., Young, S. N., Annable, L., Sourkes, T. L. (1977): Tryptophan-nicotinamide combination in depression. Lancet i, 249.

    PubMed  CAS  Google Scholar 

  56. Chouinard, G., Young, S. N., Annable, L., Sourkes, T. L. (1979): Tryptophan-no-cotinamide, imipramine and their combination in depression. Acta Psychiat. Scand. 59, 395–414.

    CAS  Google Scholar 

  57. Christiansen, J., Gram, L. F. (1973): Imipramine and its metabolites in human brain. J. Pharm. Pharmac. 25, 604–624.

    CAS  Google Scholar 

  58. Coppen, A. (1967): The biochemistry of affective disorders. Br. J. Psychiat. 113, 1237–1264.

    CAS  Google Scholar 

  59. Coppen, A., Ghose, K, Rama-Rao, V., Bailey, J., Peet, M. (1978): Mianserin and lithium in the prophylaxis of depression. Br. J. Psychiat. 133, 206–210.

    CAS  Google Scholar 

  60. Coppen, A., Peet, M. (1979): The long-term management of patients with affective disorders. In: Psychopharmacology of Affective Disorders ( Coppen, A., Peet, M, Hrsg.), S. 248–256. Oxford Medical Publications.

    Google Scholar 

  61. Coppen, A., Shaw, D. M., Farell, J. P. (1963): Potentiation of antidepressive effect of monoamine oxidase inhibitor by tryptophan. Lancet i, 79–81.

    PubMed  CAS  Google Scholar 

  62. Coppen, A., Shaw, D. M., Malleson, A., Eccleston, E., Gundy, G. (1965): Trypta-mine metabolism in depression. Br. J. Psy-ch’iat. iii, 993–998.

    CAS  Google Scholar 

  63. Coppen, A., Shaw, D. M., Herzberg, B. Baggs, R. (1967): Tryptophan in the treatment of depression. Lancet ii, 1178–1180.

    Google Scholar 

  64. Costa, E., Sandler, M., Hrsg. (1972): Monoamine oxidase — New Vistas. (Adv. Bio-chem. Psychopharmacol., Vol. 5 ). New- York: Raven Press.

    Google Scholar 

  65. Crammer, J. L., Scott, B., Woods, H., Rolfe, B. (1968): Metabolism of 14C-imi-pramine II. Excretion in the rat and in man. Psychopharmacol. 15, 207.

    Google Scholar 

  66. Crome, P., Chand, S. (1980): The clinical toxiocology of nomifensine comparison with tryciclic antidepressants. In: Royal Society of Medicine International Congress and Symposium Series Nr. 25, S. 55–58. London: Academic Press.

    Google Scholar 

  67. Chu, S. S. C., Chung, B. (1976): The cristal structure of (+)-cis-9-(3-dimethylamino-propyl)-10-methyl-2-(trifluoromethyl)-9,10- dihydroanthracene hydrochloride mono-hydrate, SKFd-28175, acetone solvate. Acta Cryst. B 32, 836–842.

    Google Scholar 

  68. Davidson, J., McLeod, M., Law-Yone, B., Linnoila, M. (1978): A Comparison of electroconvulsive therapy and combined Phenelzine-amitriptyline in refractory depression. Arch. Gen. Psychiat. 35, 639–642.

    PubMed  CAS  Google Scholar 

  69. Delini-Stula, A. (1972): The pharmacology of Ludiomil. In: Depressive Illness (Kielholz, P., Hrsg.), S. 113–123. (Int. Symp., St. Moritz, 1972 ). Hans Huber.

    Google Scholar 

  70. Delini-Stula, A. (1980): Drug-induced alterations in animal behavior as a tool for the evaluation of antidepressants: correlation with biochemical effects: In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, part 1 (Hoffmei-ster, F., Stille, G., Hrsg.), S. 505–526. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  71. Delini-Stula, A. (1980 a): Depression and antidepressants — new aspects and hypotheses. Br. J. Clin. Pract. Suppl. 7, 1980.

    Google Scholar 

  72. Delini-Stula, A., Radeke, E., Vassout, A. (1978): Some aspects of the psychopharma-cological activity of maprotiline (Ludiomil effects of single and repeated treatments. J. int. Med. Res. 6, 420–429.

    Google Scholar 

  73. Delini-Stula, A., Vassout, A. (1979): Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment. Eur. J. Pharmacol. 58, 443–451.

    PubMed  CAS  Google Scholar 

  74. Delini-Stula, A., Vassout, A. (1981): The effects of antidepressants on aggressiveness induced by social deprivation in mice and rats. Pharmacol. Biochem. Behav. 14, 33–41.

    PubMed  CAS  Google Scholar 

  75. Delini-Stula, A., Vassout, A., Bernasco-ni, R. (1982): Antiaggressive effects of maprotiline (Ludiomil): relationship to its pharmacological properties. In: Depressive illness — Far horizons? ( Delini-Stula, A., Vassout, A., Bernasconi, R, Hrsg.), S. 77–81. Cambridge Medical Publications.

    Google Scholar 

  76. De Montigny, C., Aghajanian, G. K. (1978): Tricyclic antidepressants: long-term treatment increases responsitivity of rat fo-rebrain neurons to serotonin. Science 202, 1303–1306.

    PubMed  Google Scholar 

  77. De Montigny, C., Grunberg, F., Mayer, A. (1981): Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br. J. Psychiat. 138, 252–256.

    Google Scholar 

  78. Dencker, H., Dencker, S. J., Green, A., Nagy, A. (1976): Intestinal absorption, de-methylation, and enterohepatic circulation of imipramine. Clin. Pharmacol. Therap. 19, 584–586.

    CAS  Google Scholar 

  79. Dixon, A. K. (1978): The effects of antidepressants on the social behaviour of mice after acute and chronic administration. Abst., Und World Congress of Biol. Psych., Barcelona, 1978, S. 38.

    Google Scholar 

  80. Donlon, P. T., Biertuemphel, H., Willenbring, M. (1981): Amoxapine and amitrip-tyline in the outpatient treatment of endogenous depression. J. Clin. Psychiat. 42, 11–15.

    CAS  Google Scholar 

  81. Doucet, P., Tetreault, L., Bordeleau, J. M., Blanchet, A. (1966): Evaluation comparative des propriétés antidépressives de L’opipramol, de Fimipramine et du placebo dans la dépression névrotique. 4th World Congress Psychiat., Madrid 1966. Abstracts Int. Congr. Ser. 117, 169–170.

    Google Scholar 

  82. Dunner, D. L., Fieve, R. R. (1975): Affective disorder: studies with amine precursors. Am. J. Psychiat. 132, 180–183.

    PubMed  CAS  Google Scholar 

  83. Eckmann, F. (1974): Clinical investigations with the antidepressant nomifensine. In: Systemization, Provocation and Therapy of Depressive Psychoses ( Walcher, W., Hrsg.), S. 199. Wien: Hollinek.

    Google Scholar 

  84. Eckmann, F. (1977): Clinical investigations with nomifensine. In: Alival-Sympo-sium über Ergebnisse der experimentellen und klinischen Prüfung, S. 201. Stuttgart: Schattauer.

    Google Scholar 

  85. Eckmann, F. (1980): Clinical trials with thombran, results of doubleblind studies. In: Trazodone — a New Broad Spectrum Antidepressant ( Gershon, S., Rickels, K., Silvestrini, B., Hrsg.), S. 69–74. Amsterdam: Excerpta Medica.

    Google Scholar 

  86. Eckmann, F., Immich, H. (1966): Klini-sche Untersuchung mit Esucos. Fortschritte der Medizin 84, 750–752.

    Google Scholar 

  87. Eckmann, F., Voelkl, A. (1976): Double blind clinical studies with trazodone. In: Therapy in Psychosomatic Medicine ( Antonelli, F., Hrsg.), S. 84–87. Rom: Edi-zioni Luigi Pozzi.

    Google Scholar 

  88. Edwards, J. G. (1965): Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness. Br. J. Psychiat. iii, 889–897.

    CAS  Google Scholar 

  89. Edwards, J. G. (1977): Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects. Curr. Med. Res. Opin. 5, 226–233.

    PubMed  CAS  Google Scholar 

  90. Edwards, J. G. (1979): Antidepressants and Convulsions. Lancet i, 8156–8157.

    Google Scholar 

  91. Elonen, E., Mattila, M. J. (1975): Cardiovascular effects of amitriptyline, nortriptyline, protriptyline and doxepin in conscious rabbits after subacute pretreatment with protriptyline. Med. Biol. 53, 238–244.

    PubMed  CAS  Google Scholar 

  92. Emrich, H. M. (1982): A possible role of opioid substances in depression. In: Typical and Atypical Antidepressants; Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 77–84. New York: Raven Press.

    Google Scholar 

  93. Escobar, J. I., Gomez, J., Constain, C., Rey, J., Santacruz, H. (1980): Controlled clinical trial with trazodone, a novel antidepressant. A South American experience. J. Clin. Pharm. 20, 124–130.

    CAS  Google Scholar 

  94. Everett, G. M. (1967): The dopa response potentiation test and its use in screening for antidepressant drugs. In: Antidepressant drugs (Proc. 1st Intern. Symp., Milan 1966) ( Garattini, S., Dukes, M. N. G., Hrsg.), S. 164–167. Amsterdam: Excerpta Medica.

    Google Scholar 

  95. Fabre, L. F., McLendon, D. M., Gainey, A. (1979): Trazodone efficacy in depression: a double-blind comparison with imipramine and placebo in day-hospital type patients. Curr. Ther. Res. 25, 827–834.

    Google Scholar 

  96. Feighner, J. P. (1980): Trazodone, a tria-zolopyridine derivative, in primary depressive disorder. J. Clin. Psychiat. 41, 250–255.

    CAS  Google Scholar 

  97. Feldmann, H. S., Denber, H. C. B. (1982): Long-term study of fluvoxamine: a new ra-pid-acting antidepressant. Int. Pharmaco-psychiat. 17, 114–122.

    CAS  Google Scholar 

  98. Felner, A. E., Waldmeier, P. C. (1979): Cumulative effects of irreversible MAO inhibitors in vivo. Biochem. Pharmacol. 28, 995–1002.

    PubMed  CAS  Google Scholar 

  99. Finch, N. (1975): Chemical approaches to the development of antidepressants. In: Industrial Pharmacology ( Fielding, S., Hrsg.), Vol. II, S. 1–58. Futura Publ. Co.

    Google Scholar 

  100. Findley, L. J., Hanks, G., Park, D. M., Sandler, M.: Nomifensine: effect in Parkinsonian patients not receiving L-dopa. (Nicht veröffentlicht.)

    Google Scholar 

  101. Fischer, E., Heller, B., Nachon, M., Spatz, H. (1975): Therapy of depression by phenylalanine. Arzneim.-Forsch. Drug Res. 25, 132–137.

    CAS  Google Scholar 

  102. Fjalland, B., Christensen, A. V., Hyttel, J. (1977): Peripheral and central muscarinic receptor affinity of psychotropic drugs. Naunyn-Schmiedberg’s Arch. Pharmacol. 301, 5–9.

    CAS  Google Scholar 

  103. Fleischhauer, J. (1980): Effects of mianserin. in depression in elderly patients. Curr. Med. Res. Opin. 6, 139–143.

    Google Scholar 

  104. Floru, L., Czarny, G., Tegeler, J. (1976): Doppelblindstudie mit dem neuen Antidepressivum Viloxazin im Vergleich zu Imipramin bei 50 stationären Patientinnen. Arzneim.-Forsch./Drug Res. 26, 1170–1174.

    CAS  Google Scholar 

  105. Fog, R. (1969): Rage reactions induces in rats by combination of thymoleptics and monoamine oxidase inhibitors. Pharmacol. Res. Comm. i (1), 79–83.

    CAS  Google Scholar 

  106. Fowler, C. J., Callingham, B. A., Mantle, T. J., Tipton, K. F. (1978): Monoamine oxidase A and B: a useful concept? Biochem. Pharmacol. 27, 97–101.

    CAS  Google Scholar 

  107. Fowler, P. J., Zirkle, C. L., Macko, E., Setler, P. E., Sarau, H. M., Misher, A., Tedeschi, D. H. (1977): Fluotracen; a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals. Arzneim.-Forsch./Drug Res. 27, 1589–1595.

    CAS  Google Scholar 

  108. Freeman, H. L., Wakelin, J. S., Calanca, A., Hole, G. (1982): Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 69–75. New York: Raven Press.

    Google Scholar 

  109. Freyhan, F. A. (1957): Psychomobilität, extrapyramidale Syndrome und Wirkungsweisen neuroleptischer Therapien (Chlor-fjromazin, Reserpin, Prochlorperazin). Nervenarzt 28, 504–509.

    PubMed  CAS  Google Scholar 

  110. Freyschuss, U., Sjoqvist, F., Tuck, D. (1970): Circulatory effects in man of nortriptyline, a tricyclic antidepressant drug. Pharmacol. Clin. 2, 68–71.

    Google Scholar 

  111. Fuller, R. W. (1978): Selectivity among monoamine oxidase inhibitors and its possible importance for development of antidepressant drugs. Prog. Neuropsychophar-macol. 2, 303–311.

    CAS  Google Scholar 

  112. Garver, D. L., Davis, J. M. (1979): Biogenic amine hypothesis of affective disorders. Life Sci. 24, 383–394.

    PubMed  CAS  Google Scholar 

  113. Gerner, R., Estabrook, W., Steuer, J., Jarvik, L. (1980): Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J. Clin. Psychiat. 41, 216–220.

    CAS  Google Scholar 

  114. Gershon, S., Newton, R. (1980): A multi-centered controlled evaluation of trazodone in endogenous depression. In: Trazodone. A New Broad Spectrum Antidepressant ( Gershon, S., Rickels, K., Silvestrini, B., Hrsg.), S. 42–53. Amsterdam: Excerpta Medica.

    Google Scholar 

  115. Ghose, K. (1980): Biochemical assessment of antidepressive agents. Br. J. Clin. Pharmacol. 10, 539–550.

    PubMed  CAS  Google Scholar 

  116. Glassman, A. H., Bigger, J. Th. (1981): Cardiovascular effects of therapeutic closes of tricyclic antidepressants. Arch. Gen. Psychiat. 38, 815–820.

    PubMed  CAS  Google Scholar 

  117. Glassman, A. H., Perel, J. M. (1978): Tricyclic blood levels and clinical outcome: A review of the art. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 917–922. New York: Raven Press.

    Google Scholar 

  118. Glassman, A. H., Perel, J. M., Shostak, M., Kantor, S. J., Fleiss, J. L. (1977): Clinical implication of imipramine plasma levels for depressive illness. Arch. Gen. Psychiat. 34, 197–201.

    PubMed  CAS  Google Scholar 

  119. Glassman, A. H., Platman, S. R. (1969): Potentiation of a monoamine oxidase inhibitor by tryptophan. J. Psychiat. Res. 7, 83–88.

    PubMed  CAS  Google Scholar 

  120. Glassman, A. H., Shepard, J. K., Shostak, M. (1975): Depression, delusions, and drug response. Am. J. Psychiat. 132, 716–719.

    PubMed  CAS  Google Scholar 

  121. Gold, P. W., Goodwin, F. K., Post, R. M., Robertson, G. L. (1981): Vasopressin function in depression and mania (proceedings). Psychopharmacol. Bull. 17, 7–9.

    PubMed  CAS  Google Scholar 

  122. Gong, S. N. C., Rogers, K. J. (1971): Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with pargyline. Br. J. Pharmacol. 42, 646–652.

    Google Scholar 

  123. Goodwin, F. K. Cowdry, R. W., Webster, M. H. (1978): Predictors of drug response in the affective disorders: toward an integrated approach. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 1277–1288. New York: Raven Press.

    Google Scholar 

  124. Gram, L. F., Christiansen, J. (1975): First-pass metabolism of imipramine in man. Clin. Pharmac. Ther. 17, 555–562.

    CAS  Google Scholar 

  125. Granacher, R. P., Baldessarini, R. J. (1975): Physostigmine in the acute anticholinergic syndrome associated with antidepressant and antiparkinson drugs. Arch. Gen. Psychiat. 32, 375–380.

    PubMed  CAS  Google Scholar 

  126. Greenwood, D. T. (1975): Animal pharmacology of viloxazine (Vivalan). J. Int. Med. Res. 3, Suppl. 3, 18–28.

    Google Scholar 

  127. Grüter, W., Pöldinger, W. (1982): Maprotiline. Modern Problems of Pharmacopsychiatry, Vol. 18, S. 17–48. Basel–München: Karger.

    Google Scholar 

  128. Gupta, R. N., Molnar, G. (1980): Plasma levels and tricyclic antidepressant therapy: Part I. A review of assay methods. Biophar-maceut. Drug Disposition i, 259–278.

    CAS  Google Scholar 

  129. Haefely, W. E. (1978): Behavioral and neuropharmacological aspects of drugs used in anxiety and related states. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 1359–1374. New York: Raven Press.

    Google Scholar 

  130. Hall, H., Oegren, S.-O. (1981): Effects of antidepressant drugs on different receptors in the brain. Eur. J. Pharmacol. 70, 393–407.

    PubMed  CAS  Google Scholar 

  131. Hanks, G. W. (1977): A profile of nomifensine. Br. J. Clin. Pharmacol. 4, 243–248.

    Google Scholar 

  132. Hanks, G. W., Park, D. M.: Nomifensine in Parkinson’s disease. 1980.

    Google Scholar 

  133. Harper, B., Hughes, I. E. (1977): A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserine in relation to their ability to block noradrenaline uptake. Br. J. Pharmacol. 59, 651–660.

    PubMed  CAS  Google Scholar 

  134. Harrison-Read, P. E. (1981): Synaptic and behavioural actions of antidepressant drugs. Trends Neurosci. 4, 32–34.

    Google Scholar 

  135. Haydu, G. G., Dhrymiotis, A., Quinn, G. P. (1962): Plasma imipramine level in syndromes of depression. Am. J. Psychiat. 119, 574–576.

    PubMed  CAS  Google Scholar 

  136. Heimann, H. (1977): Allgemeine methodologische Probleme der klinischen Prüfung von Psychopharmaka. Pharmakopsychiat. 10, 119–129.

    CAS  Google Scholar 

  137. Heimann, H., Schmocker, A. (1974): Zur Problematik der Beurteilung des Schweregrades psychiatrischer Zustandsbilder. Arz-neim.-Forsch./Drug Res. 24, 1004–1006.

    CAS  Google Scholar 

  138. Heller, B. (1978): Pharmacological and clinical effects of d-phenyl-alanine in depression and parkinson’s disease. In: Non-catecholic Phenylethylamines, part 1 ( Mosnaim, A. D., Wolf, M. E., Hrsg.), S. 397–417. New York: Marcel Dekker.

    Google Scholar 

  139. Herrington, R. N., Bruce, A., Johnstone, E. C., Lader, M. H. (1974): Comparative trial of L-tryptophan and ECT in severe depressive illness. Lancet 28, 731–734.

    Google Scholar 

  140. Herrington, R. N., Bruce, A., Johnstone, E. C. (1976): Comparative trial of L-tryptophan and amitriptylin in depressive illness. Psychol. Med. 6, 673–678.

    PubMed  CAS  Google Scholar 

  141. Hiele, L. J. Van (1980): L-5-hydroxytrypto-phan in depression: the first substitution therapy in psychiatry? Neuropsychobiol. 6, 230–240.

    Google Scholar 

  142. Hippius, H., Selbach, H. (1960): Klinische und theoretische Aspekte der Pharmakotherapie des depressiven Syndroms. Wien. Med. Wschr. 110, 264–268.

    Google Scholar 

  143. Hödel, J., Trum, J. M. (1977): Ergebnisse einer Feldstudie an ambulanten und stationären Patienten mit einem neuen Antidepressivum. Schweiz. Rundschau Med. (Praxis) 66, 1085–1092.

    Google Scholar 

  144. Hoffmann, I. (1977): A comparative review of the pharmacology of nomifensine. Br. J. Clin. Pharmacol. 4, 695–755.

    Google Scholar 

  145. Hole, G. (1973): Melancholie und Depression. In: Lexikon der Psychiatrie (Müller, Ch, Hrsg.), S. 331–333 bzw. 111–116. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  146. Hyttel, J. (1977): Neurochemical characterisation of a new potent and selective serotonin uptake inhibitor: Lu 10–717. Psy-chopharmacol. 51, 225–233.

    CAS  Google Scholar 

  147. Itil, T. M., Herrmann, W. M., Blassucci, D., Freedmann, A. (1978): Male hormones in the treatment of depression: effects of mesterolone. Prog. Neuro-Psychopharma-col. 2, 457–467.

    Google Scholar 

  148. Itil, T. M., Polvan, N., Engin, L., Guthrie, M. B., Hugue, M. F. (1977): Fluotra-cen (SKF-28175), a new thymo-neuroleptic with rapid action and longacting properties. Curr. Therap. Res. 21, 343–360.

    CAS  Google Scholar 

  149. Itil, T. M., Soldatos, C. (1980): Epileptogenic side effects of psychotropic drugs. JAMA 244, 1460–1463.

    PubMed  CAS  Google Scholar 

  150. Iversen, L. L. (1975): Uptake processes for biogenic amines. In: Handbook of Psycho-pharmacology ( Iversen, L. L., Iversen, S. D., Snyder, S. H., Hrsg.), Vol. 3, S. 381–442. New York: Plenum Press.

    Google Scholar 

  151. Iversen, L. L., Mackay, A. V. P. (1979): Pharmacodynamics of antidepressants and antimanic drugs. In: Psychopharmacology of Affective Disorders ( Paykel, E. S., Coppen, A., Hrsg.), S. 60–90. New York–Toronto: Oxford University Press.

    Google Scholar 

  152. Jefferson, J. W. (1975): A review of cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 37, 160–179.

    PubMed  CAS  Google Scholar 

  153. Jenner, P., Marsden, C. D. (1982): The mode of action of sulpiride as an atypical antidepressant agent. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 85–103. New York: Raven Press.

    Google Scholar 

  154. Jensen, K, Fruensgaard, K, Ahlfors, U. G. (1975): Tryptophan/Imipramine in depression. Lancet 9, 920–922.

    Google Scholar 

  155. Johnson, D. A. W. (1979): A double-blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depression. Acta. Psychiat. Scand. 59, 1–8.

    PubMed  CAS  Google Scholar 

  156. Johnson, F. N. (1975): Lithium Research and Therapy. London - New York: Academic Press.

    Google Scholar 

  157. Jukes, A. (Hrsg.) (1977): Depression: The biochemical and physiological role of Lu-diovit®. CIBA Laboratories, England.

    Google Scholar 

  158. Kaiser, C., Zirkle, C. L. (1970): Antidepressant drugs. In: Medicinal Chemistry, Part II, ( Burger, A., Hrsg.), S. 1470–1497. New York: Wiley.

    Google Scholar 

  159. Kaneko, M., Kumashiro, H., Takahashi, Y., Hoshino, Y. (1979): L-5-HTP treatment and serum 5-HT level after L-5-HTP loading on depressed patients. Neuropsychobiol. 5, 232–240.

    CAS  Google Scholar 

  160. Kanof, P., Greencard, P. (1978): Brain histamine receptors as targets for antidepressant drugs. Nature 272, 329–333.

    PubMed  CAS  Google Scholar 

  161. Karlberg, B. E., Kjellman, B. F., Kagedal, B. (1978): Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline. Acta, psychiat. scand. 58, 389–400.

    CAS  Google Scholar 

  162. Kaumann, A., Basso, N., Aramendia, P. (1965): The cardiovascular effects of the N-(-methylaminopropylimonodebenzyl)- HC1 (desmethylimipramine) and guanethi-dine. J. Pharmacol. Exp. Ther. 147, 54–64.

    PubMed  CAS  Google Scholar 

  163. Kay, D. W. K, Fahy, T., Garside, R. F. (1970): A sevenmonth double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br. J. Psychiat. 117, 667–672.

    CAS  Google Scholar 

  164. Kendell, R. E. (1976): The classification of depressions: A review of contemporary confusion. Br. J. Psychiat. 129, 15–28.

    CAS  Google Scholar 

  165. Kendell, R. E. (1978): Die Diagnose in der Psychiatrie. Stuttgart: Enke.

    Google Scholar 

  166. Kessler, K. A. (1978): Tricyclic antidepressants: mode of action and clinical use. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 1289–1302. New York: Raven Press.

    Google Scholar 

  167. Kielholz, P. (1968): Klassifizierung der depressiven Verstimmungszustände. In: Das depressive Syndrom ( Hippius, H., Selbach, H., Hrsg.), S. 342–346. München–Berlin–Wien: Urban und Schwarzenberg.

    Google Scholar 

  168. Kielholz, P., Adams, C. (1978): Diagnostik und Therapie depressiver Zustände in der täglichen Praxis. Schweiz. Rundschau Med. (Praxis) 67, 1580–1587.

    CAS  Google Scholar 

  169. Kielholz, P., Adams, C., Hrsg. (1982): Antidepressive Infusionstherapie. Eine Standortbestimmung (Internationaler Workshop, Neu Isenburg). Stuttgart - New York: G. Thieme.

    Google Scholar 

  170. Kielholz, P., Terzani, S., Gastpar, M., Adams, C. (1981): Behandlung therapiere-sistenter Depressionen ohne Elektroschock. Deutsch. Med. Wschr. 106, 671–673.

    PubMed  CAS  Google Scholar 

  171. Kirkegaard, C., Norlem, N., Lauridsen, U. B., Bjorum, N. (1975): Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression. Acta Psychiat. Scand. 52, 170–177.

    CAS  Google Scholar 

  172. Klaiber, E. L., Broverman, D. M., Vogel, W., Kobayashi, Y. (1979): Estrogen therapy for severe persistent depressions in women. Arch. Gen. Psychiat. 36, 550–554.

    PubMed  CAS  Google Scholar 

  173. Kleber, R. J. (1979): A double-blind comparative study of desipramine, hydrochloride and diazepam in the control of mixed anxiety/depression symptomatology. J. Clin. Psychiat. 40, 165–170.

    CAS  Google Scholar 

  174. Klein, D. F., Gittelman, R., Quitkin, F., Rifkin, A. (1981): Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore - London: Williams and Wilkins.

    Google Scholar 

  175. Klermann, G. L. (1978): Long-term treatment of affective disorders. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 1303–1311. New York: Raven Press.

    Google Scholar 

  176. Kline, N. S. (1958): Clinical experience with iproniacid (Marsilid). J. Clin. Exp. Psychopathol. 19, Suppl., 72–78.

    Google Scholar 

  177. Kline, N. S., Cooper, T. B. (1980): Monoamine Oxidase Inhibitors as Antidepressants. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents ( Hoffmeister, F., Stille, G., Hrsg.), S. 369–397. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  178. Kline, N. S., Sacks, W. (1980): Treatment of depression with an MAO inhibitor followed by 5-HTP — an unfinished research project. Acta Psychiat. Scand. Suppl. 280, 233–241.

    CAS  Google Scholar 

  179. Knights, A., Hirsch, S. R. (1981): „Revealed“ depression and drug treatment for schizophrenia. Arch. Gen. Psychiat. 38, 806–811.

    Google Scholar 

  180. Knorring, L. Von (1980): A double-blind trial: vivalan against placebo in depressed elderly patients. J. Int. Med. Res. 8, 18–21.

    Google Scholar 

  181. Kopera, H., Fluch, N., Harpf, H., Klein, W. W., Stulemeijer, S. (1980): Cardiovascular effects of mianserin, a comparative study with amitriptyline and a placebo in healthy subjects. Int. J. Pharmacol. Ther. Toxicol. 18, 104–109.

    CAS  Google Scholar 

  182. Kopera, H., Schenk, H. (1978): Antidepressiva und Kardiotoxizität. Beobachtungen mit Mianserin. Dtsch. med. Wschr. 103, 1371–1376.

    Google Scholar 

  183. Kretschmar, J. H. (1980): Mianserin and amitriptylin in elderly hospitalized patients with depressive illness: a double-blind trial. Curr. Med. Res. Opin. 6, 144–151.

    Google Scholar 

  184. Kröger, R. (1977): Efficacy of nomifensine in endogenous depressions by comparison with placebo. In: Alival-Symposium über Ergebnisse der experimentellen und klinischen Prüfung, S. 207. Stuttgart: Schattauer.

    Google Scholar 

  185. Kruse, W., Hoermann, M. G. (I960): Clinical evaluation of four antidepressant drugs. Curr. ther. Res. 2, 111–115.

    Google Scholar 

  186. Kugler, J., Lorenzi, E., Spatz, R., Zimmermann, H. (1979): Drug-induced paroxysmal EEG-activities. Pharmakopsychiat. 12, 165–172.

    CAS  Google Scholar 

  187. Kuhn, R. (1957): Über die Behandlung depressiver Zustände mit einem Iminodiben-zylderivat (G 22355). Schweiz. Med. Wschr., 1135–1140.

    Google Scholar 

  188. Kuhn, R. (1964): 5 Jahre medikamentöser Behandlung depressiver Zustände mit Imi-nodibenzylderivaten. In: Pharmako-Psy-chiatrie (Selbach, H., Hrsg.), S. 233–264. Darmstadt: Wissenschaftliche Buchgesellschaft.

    Google Scholar 

  189. Kuhn, R. (1970): The imipramine story. In: Discoveries in Biological Psychiatry ( Ayd, F. J., Blackwell, B., Hrsg.), S. 205–217. Philadelphia–Toronto: Lippincott.

    Google Scholar 

  190. Lader, M., Bhanji, S. (1980): Physiological and psychological effects of antidepressants in man. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents ( Hoffmeister, F., Stille, G., Hrsg.), S. 573–582. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  191. Lambourn, J., Rees, J. A. (1974): A general practioner study of dothiepin and amitriptyline. J. Int. Med. Res. 2, 210–218.

    Google Scholar 

  192. Langer, G., Karobath, M. (1980): Biochemical effects of antidepressants in man. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, part 1 ( Hoff-Meister, F., Stille, G., Hrsg.), S. 491–504. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  193. Langer, G., Koinig, G., Schönbeck, G., Aschauer, H., Lesch, O. (1982): Antidepressive Therapie mit Clomipramin-Infu-sionen. Ein klinischer Erfahrungsbericht. In: Antidepressive Infusionstherapie ( Kielholz, P., Adams, C., Hrsg.), S. 42–46. Stuttgart–New York: G. Thieme.

    Google Scholar 

  194. Langer, G., Schonbeck, G., Koinig, G., Reiter, H., Schussler, M., Aschauer, H., Lesch, O. (1980): Evidence for neuroendocrine involvement in the therapeutic effects of antidepressant drugs. In: Progress in Psychoneuroendocrinology ( Brambilla, F., Racagni, G., De Wied, D., Hrsg.), S. 197–208. Elsevier/North-Holland: Biomedical Press.

    Google Scholar 

  195. Langer, G., SchOnbeck, G., Koinig, G., Aschauer, H. (1982): Neuroendocrine me-chanismus in the therapeutic effects of antidepressant drugs: The „thyroidaxis“ hypothesis. In: Typical and Atypical Antidepressants, Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 297–302. New York: Raven Press.

    Google Scholar 

  196. Langer, S. Z., Briley, M. (1982): High-af-flnity 3H-imipramine binding: a new biological tool for studies in depression. Trends Neurosci. 4, 28–31.

    Google Scholar 

  197. Lapierre, Y. D., Sussmann, P., Ghadirian, A. (1980): Differential antidepressant properties of trazodone and amitriptyline in agitated and retarded depression. Curr. Ther. Res. 28, 845–852.

    Google Scholar 

  198. Lapin, I. P., Oxenkrug, G. F. (1969): Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 5, 132–136.

    Google Scholar 

  199. Lee, R., Spencer, P. S. J. (1977): Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. Int. Med. Res. 5, 146–156.

    CAS  Google Scholar 

  200. Lewis, J. L., Winokur, G. (1982): The induction of mania. A natural history study with controls. Arch. Gen. Psychiat. 39, 303–306.

    PubMed  CAS  Google Scholar 

  201. Lindenlaub, E., Hrsg. (1977): Nomifensin (Alival®). Stuttgart - New York: Schattau-er.

    Google Scholar 

  202. Linnoila, M., Dorrity, F., jr., Jobson, K. (1978): Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients. Am. J. Psychiat. 135, 5–7.

    Google Scholar 

  203. Lipton, M. A., Dimascio, A., Killam, K. F. (1978): Psychopharmacology: A Generation of Progress. New York: Raven Press.

    Google Scholar 

  204. Loomer, H. P., Saunders, J. C., Kline, N. S. (1957): A clinical and pharmacodynamic evaluation of iproniazid as a psychic ener-gizer. Psychiat. Res. Rep. Amerie. Psychiat. Ass. 8, 129–141.

    CAS  Google Scholar 

  205. Maas, J. W. (1979): Neurotransmitters and depression: too much, too little, or too unstable? Trends Neurosci. 2, 306–308.

    Google Scholar 

  206. Maggi, A., U’Prichard, D. C., Enna, S. J. (1980): Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur. J. Pharmacol. 61, 91–98.

    PubMed  CAS  Google Scholar 

  207. Magnus, R. V. (1975): A placebo-controlled trial of viloxazine with or without tranquilizers in depressive illness. J. Int. Med. Res. 3, 207–216.

    PubMed  CAS  Google Scholar 

  208. Magnus, R. V. (1979): Mianserin — a study of different dosage regimes in psychiatric outpatients. Br. J. Clin. Pract. 33, 251–258.

    PubMed  CAS  Google Scholar 

  209. Mahapatra, S. B. (1975): Short-term effects of viloxazine (Vivalan) compared with placebo in depression: a double-blind study. J. Int. Med. Res. 3, Suppl. 3, 70–76.

    Google Scholar 

  210. Maio, D. De, Levi-Minzi, A. Caponeri, M. A., Mellado, C., Bonicalzi, V.: Evaluation of the clinical efficacy of single doses of antidepressant. Abstracts of the 11th C. I. N. P. Congress, Vienna, Austria, 1978, S. 152.

    Google Scholar 

  211. Maitre, L., Moser, P., Baumann, P. A., Waldmeier, P. C. (1980): Amine uptake inhibitors: Criteria of selectivity. In: Biogenic Amines and Affective Disorders (Svensson, T. H., Carlsson, A., Hrsg.). Acta Psychiatr. Scand. 61, Suppl. 280, 97–110.

    Google Scholar 

  212. Maj, J., Mogilnicka, E., Klimek, V. (1979): The effect of repeated administration of antidepressant drugs on the respon-sivness of rats to catecholamine agonists. J. Neural Transm. 44, 221–235.

    PubMed  CAS  Google Scholar 

  213. Mann, J., Peselow, E. D., Collora, M., Gershon, S. (1980): D-phenylalanine in the treatment of endogenous depression. IRCS Med. Sc. 8, 116.

    Google Scholar 

  214. Matz, R. S. (1980): Clinical trials with nomifensine in the USA. In: Royal Society of Medicine International Congress and Symposium Series Nr. 25, S. 73–80. London: Academic Press.

    Google Scholar 

  215. Maxwell, R. A:, White, H. L. (1978): Tricyclic and monoamine oxidase inhibitor antidepressants: structure activity relationships. In: Handbook of Psychopharmacology (Iversen, L. L., Iversen, S. D., Snyder, S. H., Hrsg.), Vol. 14, S. 83–155. New York - London: Plenum Press.

    Google Scholar 

  216. Mayer, S. E. (1980): Neurohumoral transmission and the autonomic nervous system. In: The Pharmacological Basis of Therapeutics ( Goodman-Gilman, A., Goodman, L. S., Gilman, A., Hrsg.), S. 56–90. New York–Toronto–London: Macmillan.

    Google Scholar 

  217. McEvoy, J. P., Sheridan, W. F., Stewart, W. R. C., jr., Ban, T. A., Wilson, W. H., Guy, W., Schaffer, J. D. (1980): Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo. Br. J. Psychiat. 137, 440–443.

    CAS  Google Scholar 

  218. McSweeney, D. A.: Treatment of unipolar depression. Lancet, 510–511.

    Google Scholar 

  219. Mendels, J., Stinnett, J. L., Burns, D., Frazer, A. (1975): Amine precursors and depression. Arch. Gen. Psychiat. 52, 22–30.

    Google Scholar 

  220. Mendels, J. (1976): Lithium in the treatment of depression. Am. J. Psychiat. 133, 373–378.

    PubMed  CAS  Google Scholar 

  221. Mendlewicz, J., Linkowski, P., Rees, J. A. (1980): A double-blind comparison of do-thiepin and Amitriptyline in patients with primary affective disorder: Serum levels and clinical response. Br. J. Psychiat. 136, 154–160.

    CAS  Google Scholar 

  222. Mendlewicz, J., Youdim, M. B. H. (1980): Antidepressant potentiation of 5-hydroxy-tryptophan by L-deprenyl in affective illness. J. Affect. Dis. 2, 137–147.

    PubMed  CAS  Google Scholar 

  223. Mindham, R. H. S. (1979): Tricyclic antidepressants and amine precursors. In: Psychopharmacology of Affective Disorders ( Paykel, E. S., Coppen, A., Hrsg.), S. 23–158. New York–Toronto: Oxford University Press.

    Google Scholar 

  224. Mitchell, J., Cavanaugh, J., Arias, L., Oates, J. (1970): Guanethidine and related agents. Ill: Antagonism by drugs which inhibit the norepinephrine pump in men. J. Clin. Invest. 49, 1596–1604.

    PubMed  CAS  Google Scholar 

  225. Moises, H. W., Kasper, S., Beckmann, H. (1981): Trazodone and amitriptyline in treatment of depressed inpatients: a double-blind study. Pharmakopsychiat. 14, 167–171.

    CAS  Google Scholar 

  226. Molander, L., Randrup, A. (1976): Effects of thymoleptics on behavior associated with changes in brain dopamine. Potentiation of dopa-induced gnawing of mice. Psychopharmacol. (Berl.) 45, 261–265.

    CAS  Google Scholar 

  227. Montgomery, S. A., Montgomery, D. B., McAuley, R., Rani, S. J., Roy, D. (1982): Profile of antidepressant action of zimelidi-ne and norzimelidine compared with amitriptyline. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 35–42. New York: Raven Press.

    Google Scholar 

  228. Morozov, G., Saarma, J., Silvestrini, B. (Hrsg.) (1978): Depression and the Role of Trazodone in Antidepressant Therapy. Rom: Edizioni Luigi Pozzi.

    Google Scholar 

  229. Morpurgo, C. (1965): Drug-induced modifications of discrimated avoidance behavior in rats. Psychopharmacol. 8, 91–99.

    CAS  Google Scholar 

  230. Morpurgo, C., Theobald, W. (1965): Influence of imipramine-like compounds and chlorpromazine on the reserpine hypothermia in mice and the amphetaminehyper-thermia in rats. Med. Pharmacol, exp. 12, 226–232.

    CAS  Google Scholar 

  231. Morpurgo, C., Theobald, W. (1967): Pharmacological modifications of the amphetamine-induced hyperthermia in rats. Eur. J. Pharmacol. 2, 287–294.

    Google Scholar 

  232. Müller, P. (1981): Depressive Syndrome im Verlauf schizophrener Psychosen. Stuttgart: Enke.

    Google Scholar 

  233. Müller-Oerlinghausen, B. (1978): Bedeutung der Pharmakokinetik für die Therapie mit Antidepressiva. Pharmakopsychiat. ii, 55–62.

    Google Scholar 

  234. Murphy, D. L., Shiling, D. J., Murray, R. M. (1978): Psychoactive drug responder subgroups: possible contributions to psychiatric classifications. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killam, K. F., Hrsg.), S. 807–820. New York: Raven Press.

    Google Scholar 

  235. Murphy, J. E., Donald, J. F., Molla, A. L. (1976): Mianserine in the treatment of depression in general practice. Practitioner 217, 135–138.

    PubMed  CAS  Google Scholar 

  236. Muscettola, G., Galzenati, M., Balbi, A. (1982): SAMe versus placebo: a double-blind comparison in major depressive disorders. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 151–156. New York: Raven Press.

    Google Scholar 

  237. Naber, D., Wirz-Justice, A., Kafka, M., Wehr, T. A. (1980): Dopamine receptor bisnding in rat striatum: ultradian rhythm and its modification by chronic imipramine. Psychopharmacol. 68, 1–5.

    CAS  Google Scholar 

  238. Nagy, A. Johannson, R. (1975): Plasma levels of imipramine and desipramine in man after different routes of administration. Naunyn-Schmiedeberg’s Arch. Pharmacol. 290, 145–160.

    PubMed  CAS  Google Scholar 

  239. Nawishy, M., Trimble, R., Richens, A. (1980): Antidepressants and epilepsy: the place of nomifensine. In: Royal Society of Medicine International Congress and Symposium Series Nr. 25, S. 11–16. London: Academic Press.

    Google Scholar 

  240. Nielsen, J. L., Lund, N. O. (1981): Drug fever due to nomifensine treatment in patients with endogenous depression. Int. Pharmacopsyehiat. 16, 66–68.

    CAS  Google Scholar 

  241. Nordin, C., Siwers, B., Bertilsson, L. (1981): Bromocriptine treatment of depressive disorders. Acta Psychiat. Scand. 64, 25–33.

    CAS  Google Scholar 

  242. Nymark, M. Moller-Nielsen, I. (1963): Reactions due to the combination of mono-aminoxidase inhibitors with neuroleptics, pethidine, or methylamphetamine. Lancet 7, 524–525.

    Google Scholar 

  243. ögren, S. O., Cott, M., Hall, H. (1981): Sedative/anxiotylic effects of antidepres-sants in animals. Acta Psychiat. Scand. 63, Suppl. 290, 277–287.

    Google Scholar 

  244. Ôgren, S. O., Fuxe, K., Agnati, L. F., Gustafsson, J. A., Jousson, G., Holm, A. C. (1979): Réévaluation of the indolamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J. Neural Transm. 46, 85–103.

    PubMed  Google Scholar 

  245. Ôgren, S. O., Ross, B., Hall, H., Holm, A. C., Renyi, A. L. (1981a): The pharmacology of zimelidine: A 5-HT selective reuptake inhibitor. Acta Psychiat. Scand. 63, Suppl. 290, 127–149.

    Google Scholar 

  246. Olpe, H. R., Schellenberg, A. (1981): The sensitivity of cortical neurons to serotonin: Effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs. J. Neural Transm. 51, 233–244.

    PubMed  CAS  Google Scholar 

  247. Ortmann, R., Martin, S., Radeke, E., De-lini-Stula, A. (1981): Interaction of p-adrenoceptor agonists with the serotonergic system in rat brain; a behavioral study using L-5-HTP syndrome Naunyn-Schmie-deberg’s Arch. Pharmacol. 316, 225–230.

    CAS  Google Scholar 

  248. Ortmann, R., Waldmeier, P. C., Radeke, E., Felner, A., Delini-Stula, A. (1980): The effects of 5-HT-uptake and MAO-inhi-bitors in L-5-HTP-induced excitation in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 311, 185–192.

    CAS  Google Scholar 

  249. Overall, J. E., Hollister, L. E., Meyer, F., Kimball, I., Shelton, J. (1964): Imipra-mine and thioridazine in depressed and schizophrenic patients. J. Amer. med. Ass. 189, 605–608.

    CAS  Google Scholar 

  250. Ovhed, I. (1976): A double-blind study of flupenthixol (Fluanxol) in general practice. Curr. Med. Res. Opin. 4, 1–8.

    Google Scholar 

  251. Pare, C. M. B. (1963): Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet ii, 527–528.

    Google Scholar 

  252. Pare, C. M. B. (1979): Monoamine oxidase inhibitors in resistant depression. Int. Phar-macopsychiat. 14, 101–109.

    CAS  Google Scholar 

  253. Patch, I. C. L., Pitt, B. M., Yeo, Y. M. (1967): The direct comparison of antidepressants: imipramine and chlorprothixe-ne. J. psychiat. Res. 5, 273–280.

    PubMed  CAS  Google Scholar 

  254. Paton, D. M., Hrsg. (1979): The release of catecholamines from adrenergic neurons. Oxford: Pergamon Press.

    Google Scholar 

  255. Paykel, E. S. (1979): Predictors of treatment response. In: Psychopharmacology of Affective Disorders ( Paykel, E. S., Coppen, A., Hrsg.), S. 193–220. Oxford–New York–Toronto: Oxford University Press.

    Google Scholar 

  256. Pechanek, U., Blaicher, G., Pfannhauser, W., Woidrich, H. (1980): Beitrag zur Untersuchung biogener Amine in Käse und Fischen. Lebensmitteluntersuchung und -forschung 171, 420–424.

    CAS  Google Scholar 

  257. Pechanek, U., Woidich, H., Pfannhauser, W., Blaicher, G. (1980): Untersuchung über das Vorkommen von biogenen Aminen in Lebensmitteln. Ernährung/Nutrition 4, 58–61.

    CAS  Google Scholar 

  258. Pedersen, V. (1968): Role of catecholamines in compulsive gnawing behaviour in mice. Br. J. Pharmacol. 34, 219–220.

    Google Scholar 

  259. Peet, M., Coppen, A. (1979): The pharmacokinetics of antidepressant drugs: relevance to their therapeutic effect. In: Psychopharmacology of Affective Disorders ( Paykel, E. S., Coppen, A., Hrsg.), S. 91–107. New York–Toronto: Oxford University Press.

    Google Scholar 

  260. Pelc, I. (1977): Therapeutic profile of bu-triptyline hydrochloride in ambulatory psychiatric practice. Acta Therapeutica 3, 1–7.

    Google Scholar 

  261. Perel, J. M., Irani, F., Hurwic, M., Glassman, A. H., Manian, A. A. (1978): Tricyclic antidepressants: relationships among pharmacokinetics, metabolism and clinical outcome. In: Depressive Disorders ( Garattini, S., Hrsg.), S. 325–336. Stuttgart–New York: Schattauer.

    Google Scholar 

  262. Perel, J. M., Mendelwicz, J., Shostak, M., Kantor, S. J., Glassman, A. H. (1976): Plasma levels of imipramine in depression: environmental and genetic factors. Neu-ropsychobiol. 2, 193–201.

    CAS  Google Scholar 

  263. Peroutka, S. J., Snyder, S. H. (1980): Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210, 88–90.

    PubMed  CAS  Google Scholar 

  264. Perry, G. F., Fitzsimmons, B., Shapiro, L., Irwin, P. (1978): Clinical study of mian-serine, imipramine and placebo in depression: blood level and MHPG correlations. Br. J. Clin. Pharmacol. 5, Suppl. 1, 35–42.

    Google Scholar 

  265. Petrie, W. M., McEvoy, J. P., Wilson, W. H., Ban, T. A., Guy, W. (1980): Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study. Int. Pharmacopsy-chiat. 15, 193–196.

    CAS  Google Scholar 

  266. Pfeifer, W. M. (1971): Transkulturelle Psychiatrie. Stuttgart: G. Thieme.

    Google Scholar 

  267. Pichot, P., Guelfi, J., Dreyfus, J. F. (1975): A controlled multicenter therapeutic trial of viloxazine (Vivalan). J. Intern. Med. Res. 5, Suppl. 3, 80–87.

    Google Scholar 

  268. Pinder, R. M., Brogden, R. N., Speight, T. M., Avery, G. S. (1977): Doxepin, a review. Drugs 13, 161–218.

    PubMed  CAS  Google Scholar 

  269. Pöldinger, W. (1972): Suizidalität, Depression und Angst. In: Depressive Zustände ( Kielholz, P., Hrsg.), S. 63–72. Bern–Stuttgart–Wien: H. Huber.

    Google Scholar 

  270. Pöldinger, W. (1980): Depressive Verstim-mungszustände in der Praxis. Ihre Erkennung und Behandlung. Der praktische Arzt (Österreichische Zeitschrift für Allgemeinmedizin) 414, 875–904.

    Google Scholar 

  271. Post, M. L., Kennard, O., Horn, A. S. (1974): Possible pharmacological and theoretical implications of X-ray structure of the tricyclic antidepressant imipramine. Nature 252, 493–495.

    PubMed  CAS  Google Scholar 

  272. Post, R. M., Jimerson, D. C., Bunney, W. E., Jr. (1979): Perspectives in the treatment of the psychoneurological disorders: affective disorders. Prog. Neuro-Psychopharmacol. 3, 65–74.

    CAS  Google Scholar 

  273. Praag, H. M. Van, Korf, J. (1974): 5-hy-droxytryptophan as an antidepressant. J. Nerv. Ment. Dis. 158, 331–337.

    PubMed  Google Scholar 

  274. Prange, A. J., Jr., Loosen, P. T. (1982): Hormone therapy in depressive diseases. In: Typical and Atypical Antidepressants: Clinical Practice. ( Costa, E., Racagni, G., Hrsg.), S. 289–296. New York: Raven Press.

    Google Scholar 

  275. Prien, R. F., Klett, C. J., Caffey, E. M. (1974): Lithium prophylaxis in recurrent affective illness. Am. J. Psychiat. 131, 198– 204.

    PubMed  CAS  Google Scholar 

  276. Quitkin, F., Rifkin, A., Klein, D. F. (1979): Monoamine Oxidase Inhibitors. A review of antidepressant effectiveness. Arch. Gen. Psychiat. 36, 749–760.

    PubMed  CAS  Google Scholar 

  277. Randrup, A., Braestrup, C. (1977): Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacol. 53, 309–314.

    CAS  Google Scholar 

  278. Reginaldi, D., Tondo, L., Caliari, B., Minnai, G. P., Kukopulos, A. (1982): The role of antidepressants in rapid cyclicity. In: Typical and Atypical Antidepressants, Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 363–368. New York: Raven Press.

    Google Scholar 

  279. Renfordt, E., Busch, H., Fähndrich, E., Müller-Oerlinghausen, B. (1976): Untersuchungen einer neuen antidepressiven Substanz (Viloxazin) mit Hilfe der Zeit-Reihen-Analyse TV gespeicherter Interviews. Arzneim.-Forsch./Drug Res. 26, 1114–1125.

    CAS  Google Scholar 

  280. Rickels, K., Csanalosi, H., Newman, A., Hurowitz, J., Werblowsky, White, N. (1980): Trazodone and amitriptyline in depressed outpatients — a controlled study. In: Trazodone — A New Broad Spectrum Antidepressant ( Gershon, S., Rickels, K., Silvestrini, B., Hrsg.), S. 86–101. Amsterdam: Excerpta Medica.

    Google Scholar 

  281. Rosenthal, S. H., Bowden, C. L. (1973): A double-blind comparison of thioridazine (Mellaril) versus diazepam (Valium) in patients with chronic mixed anxiety and depressive symptoms. Curr. Therap. Res. 15, 10–12.

    Google Scholar 

  282. Rudorfer, M. V., Young, R. C. (1980): Anticholinergic effects and plasma desipra-mine levels. Clin. Pharmacol. Ther. 28, 703–706.

    PubMed  CAS  Google Scholar 

  283. Russell, G. F. M., Niaz, U., Wakeling, A., Slade, P. D. (1978): Comparative dou-ble-blind trial of mianserin hydrochloride (Organon GB 94) and diazepam in patients with depressive illness. Br. J. Clin. Pharmacol. 5, Suppl. 1, 57–66.

    Google Scholar 

  284. Saletu, B., Grünberger, J. (1980): Changes in clinical symptomatology and psychometric assessments in depressed patients during mianserin and combined amitriptyline chlordiazepoxide therapy: a dou-ble-blind comparison. Curr. Med. Res. Opin. 6, 52–62.

    Google Scholar 

  285. Salminen, J. K., Lehtonen, V. (1980): Sulpiride in depression: plasma levels and effects. Curr. Ther. Res. 27, 109–115.

    Google Scholar 

  286. Samanin, R., Jori, A., Bernasconi, S., Morpugo, E., Garattini, S. (1977): Biochemical and pharmacological studies on amineptine (SI694) and (+)-amphetamine in the rat. J. Pharm. Pharmacol. 29, 555–558.

    PubMed  CAS  Google Scholar 

  287. Samanin, R., Mennini, T., Ferraris, A., Bendotti, C., Borsini, F., Garattini, S. (1979): m-Chlorphenylpiperazin: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 308, 159–163.

    CAS  Google Scholar 

  288. Sano, I. (1971): Precursor therapy’ with active amines. I. Treatment of depression by 5-HTP (L-5-hydroxytryptophan). Psychiat. Neurol. Jap. 73, 809–815.

    CAS  Google Scholar 

  289. Scharfetter, C. (1973): Suicid. In: Lexikon der Psychiatrie ( Müller, Ch., Hrsg.), S. 500–503. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  290. Schildkraut, J. J. (1965): The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiat. 122, 509–522.

    PubMed  CAS  Google Scholar 

  291. Schmitt, H., Schmitt, H. (1966): Valeur de pharmacologie prévisionelle dans le domaine des antidépresseurs dérivés de Fiminodi-benzyle. Thérapie 21, 653–674.

    PubMed  CAS  Google Scholar 

  292. Schrold, J. (1970): Aggressive behaviour in chicks induced by tricyclic antidepressants. Psychopharmacol. (Berl.) 17, 225–233.

    CAS  Google Scholar 

  293. Sebjanic, V., Grombein, S. (1982): Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychia-trie practice. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 113–120. New York: Raven Press.

    Google Scholar 

  294. Seager, C. P., Bird, R. L. (1962): Imipramine with electrical treatment in depression-controlled trial. J. ment. Sei. 108, 704–709.

    CAS  Google Scholar 

  295. Selbach, H. (1961): Über die vegetative Dynamik in der psychiatrischen Pharmakotherapie. Dtsch. med. J. 12, 511–517.

    CAS  Google Scholar 

  296. Selbach, H. (1977): Pharmako-Psychiatrie. Darmstadt: Wissenschaftliche Buchgesellschaft.

    Google Scholar 

  297. Shaw, D. M., McSweeney, D. A., Hewland, R., Johnson, A. L. (1975): Tricyclic antidepressants and tryptophan in unipolar depression. Psychol. Med. 5, 276–278.

    PubMed  CAS  Google Scholar 

  298. Shopsin, B. (1976): Tryptophan and allo-purinol in the treatment of depression. Lancet 5, 1189–1192.

    Google Scholar 

  299. Shopsin, B., Wilk, S., Sathananthan, C., Gershon, S., Davis, K. (1974): Catecholamines and affective disorders. A critical assessment. J. Nerv. Ment. Dis. 158, 369–383.

    PubMed  CAS  Google Scholar 

  300. Sigg, E. B., Soffer, L., Gyermek, L. (1963): Influence of imipramine and related psychoactive agents on the effect of 5-hydroxytryptamine and catecholamines on the cat nictitating membrane. J. Pharmacol. Exp. Ther. 142, 13–20.

    PubMed  CAS  Google Scholar 

  301. Smith, A. H. W., Naylor, G. S., Moody, J. P. (1978): Placebo-controlled double-blind trial of mianserin hydrochloride. Br. J. Clin. Pharmacol. 5, Suppl. 1, 67–70.

    Google Scholar 

  302. Snyder, S. H., Yamamura, H. I. (1977): Antidepressants and the muscarinic acetylcholine receptor. Arch. Gen. Psychiat. 34, 236–239.

    PubMed  CAS  Google Scholar 

  303. Spiegel, R., Aebi, H.-J. (1981): Psycho-pharmakologie. Stuttgart - Berlin - Köln - Mainz: W. Kohlhammer.

    Google Scholar 

  304. Starke, K., Altmann, K. P. (1973): Inhibition of adrenergic neurotransmission by Clonidine; an action on prejunctional a-receptors. Neuropharmacol. 12, 339–347.

    CAS  Google Scholar 

  305. Stein, L. (1964): Self—stimulation of the brain and the central stimulant action of amphetamine. Fed. Proc. 23, 836–850.

    PubMed  CAS  Google Scholar 

  306. Steiner, W. G, Himwich, H. E. (1963): Effects of antidepressant drugs on limbic structures in the rabbit. J. nerv. ment. Dis. 137, 277–284.

    PubMed  CAS  Google Scholar 

  307. Stern, W. C., Harto-Truax, N., Rogers, J., Miller, L. (1982): Clinical profile of the novel antidepressant bupropion. In: Typical and Atypical Antidepressants: Clinical Practice ( Costa, E., Racagni, G., Hrsg.), S. 21–34. New York: Raven Press.

    Google Scholar 

  308. Stern, W. C., Rogers, J., Fang, V., Meltzer, H. (1979): Influence of bupropion HCl (Wellbatrin®), a novel antidepressant on plasma levels of prolactin and growth hormone in man and rat. Life Sei. 25, 1717–1724.

    CAS  Google Scholar 

  309. Stille, G. (1964): Zur pharmakologischen Prüfung von Antidepressiva am Beispiel eines Dibenzodiazepines. Arzneim.-Forsch./ Drug Res. 14, 534–537.

    CAS  Google Scholar 

  310. Stille, G. (1968): Pharmacological investigation of antidepressant compounds. Neu-ropsychopharmacol. i, 92–106.

    CAS  Google Scholar 

  311. Strain, F., Albert, W., Klicpera, C. (1979): Antidepressive treatment and mood swing patterns in endogenous depression. Pharmakopsychiat. 12, 432–437.

    Google Scholar 

  312. Sugrue, M. F. (1980): Chronic antidepressant administration and adaptiv changes in central monoaminergic system. In: Antidepressants: Neurochemical Behavioral and Clinical Perspectives ( Enna, S. T., Malick, J. B., Richelson, E., Hrsg.). New York: Raven Press.

    Google Scholar 

  313. Sulser, F., Mobley, P. L. (1980): Biochemical effects of antidepressants in animals. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, part 1 ( Hoffmeister, F., Stille, G., Hrsg.), S. 471–490. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  314. Szabadi, E., Gaszner, P., Bradshaw, C. M. (1980): The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers. Br. J. Psychiat. 137, 433–439.

    CAS  Google Scholar 

  315. Taeuber, K. (1977): Wirkungsbild von No-mifensin im pharmako-psychologischen Versuch. In: Alival (Nomifensin), ( Hoechst AG, Med. Abt., Hrsg.), S. 115–127. Stuttgart–New York: Schattauer.

    Google Scholar 

  316. Tang, S. W., Seeman, P. (1980): Effects of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn-Schmiede-berg’s Arch. Pharmacol. 311, 255–261.

    CAS  Google Scholar 

  317. Taylor, D. P., Hyslop, D. K., Riblet, L. (1980): Trazodone, a new nontricyclic antidepressant without anticholinergic activity. Biochem. Pharmacol. 29, 2149–2150.

    PubMed  CAS  Google Scholar 

  318. Theobald, W., Büch, O., Kunz, H. A. (1965): Vergleichende Untersuchungen über die Beeinflussung vegetativer Funktion durch Psychopharmaka im akuten Tierversuch. Arzneim. Forsch./Drug Res. 15, 117–125.

    CAS  Google Scholar 

  319. Theobald, W., Büch, O., Kunz, H. A., Morpurgo, C., Stenger, E. G., Wilhelmi, G. (1964): Vergleichende Pharmakologische Untersuchungen mit Tofranil®, Perto-fran® und Insidon®. Areh. Int. Pharmaco-dyn. 148, 560–596.

    CAS  Google Scholar 

  320. Ther, L., Schramm, H. (1962): Apomor-phin-Synergismus (Zwangsnagen bei Mäusen) als Test zur Differenzierung psycho-troper Substanzen. Arch. Int. Pharmaco-dyn. 138, 302–310.

    CAS  Google Scholar 

  321. Thomann, P., Hess, R. (1980): Toxicology of antidepressant drugs. In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents ( Hoffmeister, F., Stille, G., Hrsg.), S. 527–549. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  322. Thomson, J., Rankin, H., Ashcroft, G. W., Cummings, S. W.: A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. (Nicht veröffentlicht.)

    Google Scholar 

  323. Tognoni, G., Bellantuono, C., Lader, M. (1981): Epidemiological Impact of Psychotropic Drugs. Amsterdam - New York - Oxford: Elsevier/North-Holland Biomedical Press.

    Google Scholar 

  324. Tran, V. T., Chang, R. S. L., Snyder, S. H. (1978): Histamine Hi receptors identified in mammalian brain membranes with 3H-mepyramine. Proc. Natl. Acad. Sei. (USA) 75, 6290–6294.

    CAS  Google Scholar 

  325. Tuck, J. R., Punell, G. (1973): Uptake of 3H-5-hydroxytryptamine and noradrenaline by slices of rat brain incubated in serum from patients treated with chlorimipra-mine, imipramine, or amitriptyline. J. Pharm. Pharmacol. 25, 573–574.

    PubMed  CAS  Google Scholar 

  326. Van Dijk, J., Hartog, J., Hillen, F. C. (1978): Non-tricyclic antidepressants. In: Progress in Medicinal Chemistry ( Ellis, G. P., West, G. B., Hrsg.), Vol. 15, S. 262–320. Amsterdam: North-Holland Biomedical Press.

    Google Scholar 

  327. Van Praag, H. M. (1978): Amine hypotheses of affective disorders. In: Handbook of Psychopharmacology ( Iversen, L. L., Iversen, S. D., Snyder, S. H., Hrsg.), Vol. 13, S. 187–297. New York–London: Plenum Press.

    Google Scholar 

  328. Van Scheyen, J. D., Van Kämmen, D. P. (1979): Clomipramine-Induced Mania in Unipolar Depression. Arch. Gen. Psychiat. 36, 560–565.

    PubMed  Google Scholar 

  329. Veit, R. C., Friedel, R. O., Bloom, V., Bielski, R. (1980): Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin. Pharmacol. Ther. 27, 796–802.

    Google Scholar 

  330. Vinci, M. (1971): Clinical report on the use of trazodone, AF-1161, in endogenous depression. Osped. Psichiat. 39, 416–433.

    PubMed  CAS  Google Scholar 

  331. Volmat, R. (1978): Essai comparatif de la quinupramine et de l’amitriptyline dans les états dépressifs. Lyon Méd. 7, 445–447.

    Google Scholar 

  332. Von Voigtlander, P. F., Triezenberg, H. J., Losey, E. G. (1978): Interactions between Clonidine and antidepressant drugs: a method for identifying antidepressant-like agents. Neuropharmacol. 17, 375–381.

    Google Scholar 

  333. Waehrens, J., Gerlach, J. (1981): Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients. J. Aff. Dis. 3, 196–202.

    Google Scholar 

  334. Waldmeier, P. C. (1981a): Noradrenergic transmission in depression: under-or over-function? Pharmacopsychiat. 14, 3–9.

    CAS  Google Scholar 

  335. Waldmeier, P. C. ( 1981 b): The role of uptake inhibition in the antidepressant effect of drugs. In: Depression and Antidepressants (Friedman, E., Mann, J., Gershon, S., Hrsg.). New York: Raven Press.

    Google Scholar 

  336. Waldmeier, P. C., Baumann, P. A., Wilhelm, M., Bernasconi, R., Maitre, L. (1977): Selective Inhibition of noradrenaline and serotonin uptake by C-49802-B-Ba and CGP 6085 A. European J. Pharmacol. 46, 387–391.

    CAS  Google Scholar 

  337. Walinder, J., Skott, A., Carlsson, A., Nagy, A., Roos, B.-E. (1976): Potentation of the antidepressant action of clomipramine by tryptophan. Arch. Gen. Psychiat. 33, 1384–1389.

    PubMed  CAS  Google Scholar 

  338. Weitbrecht, H. J. (1972): Depressive und manische endogene Psychosen. In: Psychiatrie der Gegenwart: Forschung und Praxis, II/l ( Kisker, K. P., Meyer, J. E., Müller, M., Strömgren, E., Hrsg.), S. 83–140. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  339. Wheatley, D. (1977): Hormone Replacement Therapy in Post-Menopausal Depression and the Female Climacteric. Curr. Med. Res. Opin. 4, Suppl. 3, 37–45.

    Google Scholar 

  340. Wheatley, D. (1981): The side-effects profile of the new antidepressants. In: New Directions in Antidepressant Therapy, Vol. 46, S. 87–93. London: The Royal Society of Medicine.

    Google Scholar 

  341. Widlocher, D., Lecrubier, Y., Jouvent, R., Puech, A. J., Simon, P. (1977): Antidepressant effect os salbutamol. Lancet i, 767–768.

    Google Scholar 

  342. Wilhelm, M., Kuhn, R. (1970): Versuch einer stereochemisch-strukturellen Klassifizierung der Trizyklus-Psychopharmaka mit Einschluß der Dibenzobicyclooctadiene. Pharmakopsychiat. Neuro-Psychopharma-col. 3, 317–332.

    CAS  Google Scholar 

  343. Wittenborn, J. R. (1975): Theoretical backgrounds and methods of tests in clinical psychopharmacology: The psychologist’s point of view. In: Assessment of Pharmacodynamic Effects in Human Pharmacology (Hippius, H., Hrsg.), S. 3 — 10. Stuttgart - New York: Schattauer.

    Google Scholar 

  344. Wolstenholme, G. E. W., Knight, J., Hrsg. (1976): Monoamine oxidase and its inhibition. (CIBA Foundation Symposium 39.) Amsterdam: Elsevier, Excerpta Medi-ca/North-Holland.

    Google Scholar 

  345. Youdim, M. B. H., Paykel, E. S., Hrsg. (1981): Monoamine oxidase inhibitors: The state of the art. Chichester: Wiley.

    Google Scholar 

  346. Young, J. P. R., Hughes, W. C., Lader, M. H. (1976): A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br. Med. J. i, 1116–1118.

    PubMed  CAS  Google Scholar 

  347. ZapletAlek, M., Lisonkova, D., HajCman, L. (1962): Nase zkusenosti s kli-nickym pouzitim imipraminu a levomepro-mazinu u depresivnich stavu. Activ. nerv. sup. (Praha) 4, 208–217.

    CAS  Google Scholar 

  348. Zeelen, F. J. (1980): Antidepressants: chemistry (structure and activity). In: Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, part 1 ( Hoffmeister, F., Stille, G., Hrsg.), S. 351–368. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  349. Ziegler, V. E., Taylor, J. R., Wetzel, R. D., Biggs, J. T. (1978): Nortriptyline plasma levels and subjective side effects. Br. J. Psychiat. 132, 55–60.

    Google Scholar 

  350. Zung, W. W. K. (1980): A comparison of the effects of viloxazine and placebo on the sleep of depressed patients. Curr. Ther. Res. 27, 152–156.

    Google Scholar 

Download references

Authors
  1. R. Paioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Waldmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Delini-Stula
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Schönbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Beckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Universitätsklinik Wien, Lazarettgasse 14, A-1097, Wien, Österreich

    Gerhard Langer (Oberarzt) (Oberarzt)

  2. Osianderstraße 22, D-4700, Tübingen 1, Bundesrepublik Deutschland

    Hans Heimann (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen) (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag/Wien

About this chapter

Cite this chapter

Paioni, R., Waldmeier, P., Delini-Stula, A., Langer, G., Schönbeck, G., Beckmann, H. (1983). Antidepressiva: Grundlagen und Therapie. In: Langer, G., Heimann, H. (eds) Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7645-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7645-0_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7646-7

  • Online ISBN: 978-3-7091-7645-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation